Synthesis,physicochemical and in vitro biological evaluation of 99mTc-cefepime radioconjugates,and development of DTPA-cefepime single vial kit formulation for labelling with technetium-99m

Journal of Radioanalytical and Nuclear Chemistry - In the present work the synthesis, physicochemical properties and biological evaluation of cefepime (CFM) labelled with technetium-99m were...     

Formamidine sulfinic acid as reducing agent in technetium-99m rhenium sulfide labelling

Labelling kinetic studies, radiochemical characterization and particle size evaluation of technetium-99m rhenium sulfide colloid using formamidine sulfinic acid as reducing agent are described. Comparison with the same colloid which makes use of Sn-sodium pyrophosphate complex as reducing agent has shown higher labelling yields, simplification of labelling procedure and a longer shelf life when formamidine sulfinic acid is used.     

Derivatization of dihydrotetrabenazine for technetium-99m labelling towards a radiotracer targeting vesicular monoamine transporter 2

The development of technetium-99m-labelled dihydrotetrabenazine (DTBZ) derivative for vesicular monoamine transporter 2 (VMAT2) tracing could be a benefit for single photon emission computed tomography (SPECT) imaging due to easy labelling chemistry and great availability through nuclide generator system. Here, we successfully prepared a technetium-99m-labelled DTBZ derivative and subsequently evaluated its biological activity targeting VMAT2. A novel combination of the bisaminoethanethiol (BAT) chelator scaffold with the biologically active DTBZ vector was performed to synthesize the labelling precursor BAT-P-DTBZ, and it was accomplished in six steps. The technetium-99m labelling was carried out in the radiochemical study of BAT-P-DTBZ conjugate, and the radiolabelling conditions were investigated and optimized. Under the optimized labelling condition, ^99mTc-BAT-P-DTBZ was acquired with a good radiochemical purity of above 95 %. The quality control test showed that ^99mTc-BAT-P-DTBZ is stable over 6 h and it has a suitable lipophilicity, suggesting successful appositeness for the needs of routine biological evaluation experiments. The in vitro biological evaluation revealed that ^99mTc-BAT-P-DTBZ could bind to VMAT2 sites. The in vivo biodistribution study clearly indicated that the pancreas (VMAT2-enriched region) displays relatively high uptake of ^99mTc-BAT-P-DTBZ among all organs in mice. The specific VMAT2 binding signal of ^99mTc-BAT-P-DTBZ was separately detected in the in vitro and in vivo biological evaluation. Therefore, ^99mTc-BAT-P-DTBZ might be a potential imaging agent for monitoring VMAT2 binding sites in the pancreas.     

Labeling of ursodeoxycholic acid with technetium-99m for hepatobiliary imaging

An adopted method for the preparation of high radiochemical purity ^99mTc-ursodeoxycholic acid (UDCA) was conducted with a high radiochemical yield up to 97.5 %. The reaction proceeds well using 2 mg UDCA, 50 μg tin chloride in solution of pH 8 at room temperature for 30 min. The radiochemical yield was up to 97.5 % as pure as ^99mTc-UDCA. Different chromatographic techniques (paper chromatography and electrophoresis) were used to evaluate the radiochemical yield and purity of the labeled product. Biodistribution studies were carried out in Albino Swiss mice at different time intervals after administration of ^99mTc-UDCA. The uptake of ^99mTc-UDCA in the liver gave the chance to diagnose it. The results indicate that the labeled compound cleared from the systematic circulation within 2 h after administration and majority of organs showed significant decrease in uptake of ^99mTc-UDCA. Finally, the liver uptake was high and the results indicate the possibility of using ^99mTc-UDCA for hepatobiliary imaging.     

Tropolone,a ligand for a lipophilic chelate with technetium-99m

A lipophilic chelate formed from tropolone and^99mTc is described. Radiochemical yields of the chelate were 90–95%. The radiochemical purity of neutral chelate as determined by HPLC was greater than 95%. The octanol/water partition coefficient of the chelate was 3.2 Whole-body distribution studies of the labeled chelate were carried out in rats.     

Preparation of L-asparagine complex of technetium-99m

Attempts have been made to employ magnesium oxide as the preconcentration agent for determination of trace metal sin seawater by neutron activation analysis. Hydrous magnesium oxide can efficienthy adsorb most cationic transition metals and rare earths in a simple water system. The adsorption behavior is believed to depend mainly from the association of the cationic species of the metals with MgO ₂ ^2– adsorbent. In seawater matrix some of the metal ions such as Hg²⁺, Ni²⁺, etc. may become inefficiently adsorbed owing to the formation of highly stable metal-chloro complexes with chloride ion. Usually the adsorption efficiencies of the metals can be recovered to be as high as the case in the simple water system if an acidified seawater (to pH1) is subjected to the adsorption experiment. In practice, a large volume of seawater (5 1) is stirred with a small amount of hydrous MgO (1 g). Thereafter, the trace metals adsorbed MgO is separated and taken to be neutron activated. The abundant sodium ion and ubiquitous bromide ion can be obviated by the adsorption process, thereby beneficial to the -spectrometry of the metals enriched on MgO.     

S-Trityl protection of bis-amino bis-thiol (BAT) chelator enables flexible derivatisation and facile labelling with technetium-99m

We have coupled S,S′-bis-trityl N-BOC protected 1,2-ethylenedicysteamine, a bis-amino bis-thiol (BAT) tetraligand, via a propylene or ethylene spacer to several biologically active molecules including 2-nitroimidazole, desethylflumazenil, a beta-CIT analogue, glucose and 2-(2′-hydroxy-4′-aminophenyl)-1,3-benzothiazole. The conjugates were efficiently labelled with technetium-99m by consecutive heating of the S,S′-bis-trityl protected ligand in hydrochloric acid followed by neutralisation and heating in the presence of ^99mTc-tartrate. The S,S′-bis-trityl BAT chelator is an interesting synthon that allows both flexible derivatisation with various biologically active molecules and facile labelling with technetium-99m.     

Studies on the chemistry of technetium-99m radiopharmaceuticals

Technetium-DTPA (diethylenetriaminepentaacetic acid) and Technetium N-(2,6-diethylacetanilido)iminodiacetic acid complexes were prepared at carrier free level and milligram levels using different methods. They were compared by paper electrophoresis. Their composition and stability constants were studied by solvent extraction.     

Determination of complex forming conditions of 8-hydroxyquinoline with technetium-99m

Complex forming conditions of 8-hydroxyquinoline with^99mTc have been specified.^99mTcO₄ ^– has been reduced by SnCl₂ to a lower oxidation level. Labeling yields have been determined by ITLC (Instant Thin Layer Chromatography). Various parameters, such as pH, temperature, reaction time, ligand to SnCl₂ ratio, which can affect the labeling yields, have been determined. Optimum conditions are 4–7 for pH; 15–20°C (room) for temperature; 1.55 for ligand to SnCl₂ ratio and 5 min for reaction time.     

Radiolabeling of low molecular weight d-galactose-based glycodendrimer with technetium-99m and biodistribution studies

Glycodendrimers are neoglycoconjugates that can be considered as bioisosters of glycoproteins, since they can mimic the multivalent interactions of lectin-carbohydrate. The ability of glycodendrimers to present multivalent interactions with lectins as compared to a monovalent ligand is referred to as “cluster effect”. It is expected that, because of the cluster effect, glycodendrimers would result in a better association with lectins than mono-carbohydrate anchored systems. Radioisotopes are useful to evaluate biodistribution of molecules. This study is important to obtain information about molecule–receptor interactions. Indeed, such study can provide an exquisite tool to evaluate the affinity of certain molecules to specific areas in the body, leading to the development of new radiopharmaceuticals and/or drug delivery systems. Herein, we describe a d-galactose coated low molecular weight PAMAM G0 dendrimer that was successfully radiolabeled with technetium-99m. Biodistribution studies and scintigraphic images were performed in healthy mice. It was observed high liver uptake which was significantly reduced in blocking studies, indicating hepatic specificity. Therefore, low molecular weight glycodendrimer can be considered as useful platform for selective targeting of drugs to the liver and to assess hepatic function.     

Platelet-12 lipoxygenase targeting via a newly synthesized curcumin derivative radiolabeled with technetium-99m

Background

One of the most popular techniques for cancer detection is the nuclear medicine technique. The present research focuses on Platelet-12-lipoxygenase (P-12-LOX) as a promising target for treating and radio-imaging tumor tissues. Curcumin was reported to inhibit this enzyme via binding to its active site.

Results

A novel curcumin derivative was successfully synthesized and characterized with yield of 74%. It was radiolabeled with the diagnostic radioisotope technetium-99m with 84% radiochemical yield and in vitro stability up to 6 h. The biodistribution studies in tumor bearing mice confirmed the high affinity predicted by the docking results with a free binding energy value of (ΔG ?50.10 kcal/mol) and affinity (13.64 pki) showing high accumulation in solid tumor with target/non-target ratio >6.

Conclusion

The newly synthesized curcumin derivative, as a result of a computational study on platelet-12 lipoxygenase, showed its excellent free binding energy (?G ?50.10 kcal/mol) and high affinity (13.64 pKi). It could be an excellent radio-imaging agent that targeting tumor cells via targeting of P-12-LOX.

Open image in new window

Graphical abstract This novel curcumin derivative was successfully synthesized and radiolabeled with technetium-99m and biologically evaluated in tumor bearing mice that showed high accumulation in solid tumor with target/non-target ratio >6 confirming the affinity predicted by the docking results. Predicted binding mode of a new curcumin derivative in complex with 12-LOX active site. b Curcumin itself in the 12-LOX active site biological distribution of ^99mTc-curcumin derivative complex in solid tumor bearing Albino mice

     

Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with Substance P

Two types of technetium-99m complexes: (i) with the Hynic ligand linked to Substance P(1–11) and (ii) of the type ‘4 + 1’ consisting of tetradentate tripodal chelator tris(2-mercaptoethyl)-amine and monodentate isocyanide ligand previously coupled with Substance P(1–11), have been prepared on the n.c.a. scale. The obtained conjugates exhibit different lipophilicity and high stability in neutral aqueous solutions, even in the presence of excess concentration of histidine/cysteine competitive standard ligands. The conjugate (^99mTc(NS₃)(CN))₂–SP containing two technetium-99m species in the molecule may be expected to be an extremely good diagnostic radiopharmaceutical.     

Synthesis and preliminary biological evaluation of a technetium-99m labeled thymidine analog

The synthesis and labeling of ^99mTc-N³-（N’-[2-sulfanyl-ethylamino）acetyl]-2-aminoethyl-sulfanyl-1-hexanamide}thymidine (^99mTc-NHT) were studied.In the presence of sodium glucoheptonate（GH） and ethylene diamine tetraacetic acid（EDTA）,^99mTc-NHT was obtained by using bisaminoethanethiol（N₂S₂） as a bifunctional coupling agent.The radiochemical purity of the ^99mTc-NHT was over 95%.Biodistribution of ^99mTc-NHT was performed in hepatoma HepA tumor-bearing mice.At 2 h p.i.,the ratios of tumor-to-muscle,tumor-to-bone and tumor-to-blood were 4.41±0.32,2.45±0.24 and 1.51±0.18,respectively.     

Direct labeling of doxorubicin with technetium-99m: its optimization, characterization and quality control

Doxorubicin (DOX) is an anthracycline antineoplastic and one of the most potent and widely used drugs in clinical oncology. It is used in the treatment of a wide variety of cancers. The aim of this study was the direct labeling of DOX with ^99mTc; its optimization, characterization and quality control of the radiolabeled DOX. Labeling efficiency was determined by paper chromatography. More than 92% labeling was obtained at pH 6?C7, 10?C12???g stannous chloride and 200???g of DOX. The stability of ^99mTc?CDOX was studied up to 5?h. All the experiments were performed at room temperature (25±?2?°C). The characterization of the labeling compound was performed by HPLC and electrophoresis. Electrophoresis indicates that labeled DOX has no charge and HPLC shows single specie of labeled compound.     

Preparation of new technetium-99m NNS/X complexes and selection for brain imaging agent

Quantification of regional cerebral blood flow(rCBF) plays an important role in the diagnosis ofvarious cerebrovascular and neurological diseases. Innuclear medicine, brain perfusion imaging can providesituation of whole or regional cerebral blood flowperfusion (CBF or rCBF) to neurologists, help to findabnormality of cerebral blood flow before cere-brovascular and neurological diseases induce patho-logical changes in configuration or structure of brain.They offer important information for …     

In vitro kinetics of red blood cell labelling with99mTc in association with stannous pyrophosphate

The half time for the^99mTc labelling of red blood cells which have been pretreated with stannous pyrophosphate is determined in an in vitro system and shown to be approximately 5 minutes.     

Chemical and biological properties of verapamil labeled with technetium-99m: A potential myocardial imaging agents

On the base of property to enter into myocardial cells as a calcium channel blocker, verapamil was labeled with technetium-99m in order to investigate the possibility to obtain new radiopharmaceutical for myocardial imaging. The conditions of labeling verapamil with technetium-99m for different ammounts of stannous(II) ion, mannitol, cystein and pH range 2.5–3.5 were examined. Investigation of radiochemical purity (>95%) and biodistribution of ^99mTc-verapamil in rats showed that it was stable during 2 hours after labeling. Accumulation of ^99mTc-verapamil in heart was 1.2% and in liver 9.4%, 5 minutes after injection. Biodistribution of ^99mTc-verapamil in rats in conditions of stress, pharmacologically caused by dipiridamol, showed that the elimination of ^99mTc-verapamil from the heart was slower related to the control group. In the group of rats previously treated with isoproterenol uptake of ^99mTc-verapamil in heart was lower related to the control group (0.7% versus 1.0%) 5 minutes after injection. Lipophilicity of ^99mTc-verapamil was examined by determination of partition coefficient (log P = 0.62) and protein binding (79%). Imaging studies on dogs provided relatively good myocardial images with partially overlap of activity in the lung and liver.